Wirtz, Veronika J.

Essential medicines for universal health coverage

Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., et al. (2017) · The Lancet

Pharmaceutical Economics and PolicyHealthcare Systems and Reforms

Cited by 661

Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J. (2013) · PLoS ONE

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 135

Consumption of systemic antibiotics in India in 2019

Koya, S. F., Ganesh, S., Selvaraj, S., Wirtz, V. J., Galea, S., & Rockers, P. C. (2022) · The Lancet Regional Health - Southeast Asia

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 102

Analysing policy interventions to prohibit over‐the‐counter antibiotic sales in four Latin American countries

Wirtz, V. J., Herrera‐Patino, J. J., Santa‐Ana‐Tellez, Y., Dreser, A., Elseviers, M., & Vander Stichele, R. H. (2013) · Tropical Medicine & International Health

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 76

A new entity for the negotiation of public procurement prices for patented medicines in Mexico

Gómez-Dantés, O., Wirtz, V., Reich, M., Terrazas, P., & Ortiz, M. (2012) · Bulletin of the World Health Organization

Pharmaceutical Economics and PolicyHealthcare Systems and Reforms

Cited by 37

Reforming antiretroviral price negotiations and public procurement: the Mexican experience

Adesina, A., Wirtz, V. J., & Dratler, S. (2013) · Health Policy and Planning

Pharmaceutical Economics and PolicyHIV/AIDS Impact and Responses

Cited by 32